PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY

por Mein, Calvin, Dugel, Pravin U., Feiner, Leonard, Drenser, Kim, Miller, Daniel, Benz, Matthew, Meunier, Esmeralda, Moro, Lionel, Fineman, Mitchell S.
Publicado 2020

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)

por Drenser, Kimberly A, Pieramici, Dante J, Gunn, Joseph M, Rosberger, Daniel F, Kozma, Petra, Fineman, Mitchell S, Duchateau, Luc, Khanani, Arshad M
Publicado 2021

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

por Dugel, Pravin U., Khanani, Arshad M., Berger, Brian B., Patel, Sunil, Fineman, Mitchell, Jaffe, Glenn J., Kozma-Wiebe, Petra, Heier, Jeffrey
Publicado 2021

NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEA

por Jung, Jesse J., Zeng, Anne, Komati, Rahul, Mackin, Anna G., Skondra, Dimitra, Yonekawa, Yoshihiro, Fineman, Mitchell S., Ezon, Isaac, Rofagha, Soraya, Hoang, Quan V.
Publicado 2023